. 2022 Mar 24;2022:7918604. doi: 10.1155/2022/7918604

Table 2.

Vaccination coverage during COVID-19 pandemic (2020 compared to 2018 and 2019).

	2018	2019	2020	2018, 2019	Avg. 2018, 2019 vs. 2020
	% (n)^†	% (n)^†	% (n)^†	Avg. %	% change
BCG	94 (189942)^‡	86 (180313)^‡	76 (167745)^‡	90	14
Hexavalent-1^§	95 (189676)^¶	90 (184122)^¶	78 (168208)^¶	93	15
Hexavalent-2^§	96 (191540)^¶	90 (183262)^¶	78 (169043)^¶	93	15
Hexavalent-3^§	96 (190112)^¶	89 (183093)^¶	77 (166701)^¶	93	16
Rotavirus-1	94 (187411)^¶	88 (179284)^¶	77 (165090)^¶	91	14
Rotavirus-2	95 (188615)^¶	88 (179874)^¶	77 (165231)^¶	92	15
Rotavirus-3	93 (185071)^¶	86 (176605)^¶	75 (161585)^¶	90	15
OPV-1	96 (191540)^¶	90 (183262)^¶	78 (169043)^¶	93	15
OPV-2	96 (190112)^¶	89 (183093)^¶	77 (166701)^¶	93	16
OPV-3	92 (182975)^¶	87 (178913)^¶	76 (164475)^¶	90	14
OPV-booster	89 (172226)^‖	97 (176845)^‖	86 (164611)^‖	93	7
Measles	92 (182975)^¶	87 (178913)^¶	76 (164872)^¶	90	14
MMR-1	96 (186923)^‖	99 (181213)^‖	90 (172497)^‖	98	8
MMR-2	89 (172226)^‖	97 (176845)^‖	87 (167381)^‖	93	6
DPT-booster	89 (172226)^‖	97 (176845)^‖	86 (164611)^‖	93	7
	Avg. % (Σ n )	Avg. % (Σ n )	Avg. % (Σ n )	P value ^# 2020 vs. 2018	P value ^# 2020 vs. 2019
All-vaccines	93.5 (2,773,570)	90.7 (2,702,482)	79.6 (2,497,794)	<0.001^∗	0.001^∗

Avg.: average; BCG: Bacillus Calmette–Guérin; DPT: diphtheria, pertussis, and tetanus; MMR: measles, mumps, and rubella; OPV: oral polio vaccine; vs.: versus. ^†n: number of vaccine doses administered. ^‡Crude birth; 2018: 202711; 2019: 208792; 2020: 220057. ^§Hexavalent vaccine: diphtheria, pertussis, tetanus (DPT); Haemophilus influenzae type b (Hib); hepatitis B vaccine (HBV); and inactivated polio vaccine (IPV). ^¶Surviving infants; 2018: 198656; 2019: 204616; 2020: 215656. ^‖Expected population of 1-2 years old; 2018: 194417; 2019: 182244; 2020: 192077. ^#Kruskal–Wallis test. ^∗P value <0.05 indicates significant differences.